Best PET-CT with Gallium 68 (DOTA) Doctors Worldwide — TOP 83

Professor Bulent Karagoz is a medical oncologist who formerly led the Internal Diseases Department at Istanbul Okan University.

• Treats neuroendocrine tumors often assessed with PET-CT Gallium 68 (DOTA) imaging
• Specializes in tumor biology to understand how specific molecules help cancer grow
• Authored over 40 scientific publications focused on tumor immunology and immunotherapy
• Member of the European Head and Neck Society and Turkish Medical Oncology Association
• Uses targeted therapies to attack cancer at a molecular level

Professor Kezban Berberoglu is a nuclear medicine specialist at Anadolu Medical Center. She completed advanced radiology training at the Johns Hopkins University School of Medicine.

• Specializes in PET-CT with Gallium 68 for neuroendocrine and prostate cancers
• Expert in targeting cancer cells using Lutetium-177 and Actinium-225 therapies
• Completed specialized PET/CT and SPECT/CT imaging training at Johns Hopkins
• Member of the European Association of Nuclear Medicine (EANM)
• Serves on the oncology work group for the Turkish Society of Nuclear Medicine

Dr. Ilker Tinay leads urological oncology at Anadolu Medical Center. He uses PET-CT with Gallium 68 to provide highly accurate staging for urological cancers.

• Specializes in Gallium 68 PSMA and DOTATATE imaging for prostate and kidney diseases
• Serves as an Executive Board Member of the Association of Urooncology
• Fellow of the American College of Surgeons – a mark of high surgical standards
• Received the Scientific Research Award from the Urooncology Association for his oncology work
• Secretary of the Bladder Tumors Research Group within the Association of Urooncology

Dr. Gorkem Turkkan is a radiation oncologist at Hisar Hospital Intercontinental in Istanbul. He has successfully completed over 2,500 radiotherapy sessions using MR-Linac technology. Dr. Turkkan focuses on MRI-guided radiotherapy and stereotactic treatments for various cancers. He conducted clinical research on proton therapy at the MAASTRO Clinic in the Netherlands.

• Specializes in prostate, breast, lung, and head and neck cancer treatments.
• Uses VMAT and IMRT techniques to target tumors with precision.
• Maintains membership in the European Society of Radiotherapy and Oncology.
• Works at a JCI-accredited hospital serving 500,000+ patients annually.

Dr. Tamer Aksoy is a nuclear medicine specialist at Hisar Hospital Intercontinental in Istanbul. He specializes in PET/CT examinations and radionuclide therapies. Dr. Aksoy completed clinical research as an observer at the Netherlands Cancer Institute in Amsterdam. He holds the title of Associate Professor.

• Member of the European Association of Nuclear Medicine.
• Expert in PET/CT imaging using Gallium 68 for precise diagnostics.
• Focuses on radionuclide therapy for oncology patients.
• Works at Hisar Hospital, which holds JCI accreditation for safety and quality.

Professor Zielinski is the chairman of the Vienna Cancer Center and a leading oncologist. He specializes in personalized medicine and imaging for complex cancer cases.

• Directs the International Oncology Center at Wiener Privatklinik for advanced diagnostics
• Uses PET-CT with Gallium 68 to identify specific tumor biology for targeted therapy
• Published over 600 scientific papers on cancer research and treatment outcomes
• Former head of the Cancer Center at Vienna General Hospital
• Member of ASCO, the world leading professional organization for oncology doctors

Dr. Andreas Sesterhenn is the Chief Physician of Otolaryngology and Plastic Surgery at Solingen Clinic. He specializes in tumor removal for the head, neck, and upper airways. Dr. Sesterhenn uses robotic systems for interventions through incisions as small as 1 cm. Developed expertise in surgical medicine through training in the USA and Germany.

• Performs endoscopic operations through the nose to treat complex tumors.
• Author of over 75 scientific publications in the field of head and neck surgery.
• Treats larynx, thyroid, and tongue cancer using tumor-sparing techniques.
• Works at Solingen Clinic, ranked among the top hospitals in Germany by Focus magazine.

Dr. Amos Toren is a pediatric hemato-oncologist at Sheba Medical Center. He served as Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division. Dr. Toren holds a PhD in Human Genetics. He specializes in CAR T-cell therapy and bone marrow transplantation for children. Forbes Israel has recognized his expertise in hematology.

• Served as the Head of the Hematology Division at Tel Aviv University.
• Treats complex cases of leukemia, lymphoma, and rare pediatric cancers.
• Member of the American Society of Hematology and European Group for Blood and Marrow Transplantation.
• Collaborates on research with the NIH and St. Jude Children’s Research Hospital.

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. Almog Ben Yaacov is a senior oncological surgeon at Sheba Medical Center. He completed specialized surgical oncology training at Memorial Sloan Kettering Cancer Center in New York.

• Specializes in complex abdominal malignancies where PET-CT with Gallium 68 (DOTA) aids tumor detection
• Fellowship trained at King's College London in NanoKnife technology for precise tumor destruction
• Board certified in both General Surgery and Surgical Oncology
• Completed advanced training in liver ablation and specialized gastrointestinal surgery in France
• Published research on the correlation between intraoperative findings and pathological results

Prof. Amit Tirosh heads the Neuroendocrine Tumors Service at Sheba Medical Center. He uses PET-CT with Gallium 68 for the precise staging of endocrine tumors.

• Completed advanced training in neuroendocrine tumors at the National Institutes of Health in the USA
• Serves on an international expert panel for von Hippel–Lindau disease
• Authored 40+ medical publications in journals like Radiology and JAMA
• Member of the European Neuroendocrine Tumors Society
• Leads a specialized laboratory focusing on bioinformatics in endocrine oncology

Dr. Sefik Igdem is a radiation oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating head, neck, and prostate cancers. He currently serves as a Professor at Demiroğlu Bilim University. Dr. Igdem uses Truebeam STx and Halcyon systems for accurate radiotherapy.

• Specializes in conformal treatments for complex tumor cases.
• Treats various conditions including lung, breast, and brain tumors.
• Practices at a JCI-accredited hospital that serves 200,000 patients annually.
• Completed his radiation oncology training at the Istanbul University Cerrahpaşa Faculty.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Mustafa Solak completed an advanced oncology fellowship at the MD Anderson Cancer Center in the USA. For patients needing PET-CT with Gallium 68, he provides expert interpretation for staging complex gastrointestinal and neuroendocrine tumors.

• Specializes in systemic therapies for breast, lung, and gastrointestinal cancers
• Fellowship graduate of the Hacettepe University Cancer Institute
• Oversees immunotherapy and targeted treatments for advanced stages of disease
• Provides radioiodine therapy for thyroid disorders at Hisar Hospital

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center. He uses PET-CT with Gallium 68 (DOTA) to identify neuroendocrine tumors and guide systemic therapies.

• Trained at Istanbul University Cerrahpaşa, one of the nation's top medical schools
• Former oncology expert at Gülhane Military Medical Academy
• Specialist in internal medicine and medical oncology
• Member of the Turkish Medical Oncology Society
• Uses immunotherapy and targeted therapy for various cancer types

Dr. Aksoy is an Assistant Professor at Istanbul University Cerrahpaşa Medical Faculty. He leads specialized imaging at Hisar Intercontinental Hospital, including PET-CT with Gallium 68.

• Expert in interventional radiology – uses imaging to perform precise, minimally invasive procedures
• Member of the European Society of Radiology and the International Society of Radiology
• Specializes in whole-body imaging – identifies tumors and spread throughout the body
• Contributed academic research to 13 national and international medical congresses

Assoc. Prof. Dr. Heves Sürmeli is a specialist in Internal Medicine and Medical Oncology. She received her medical degree (M.D.) from Eskişehir Osmangazi University in 2004. She completed her Internal Medicine residency at Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul (2005–2010). She then completed subspecialty training in Medical Oncology at the same hospital (2014–2017).

At the same center, she served as a Medical Oncology Specialist (2017–2023). She then worked as Administrative and Clinical Director (2023–2026). Her clinical interests include breast, lung, gynecologic, gastrointestinal, and urologic cancers.

She has published many articles in international peer‑reviewed journals. She has presented at national and international conferences. She is active in professional societies. She has received several awards.